Hosted on MSN11mon
Ypsomed agrees for pen needle and BGMs businesses sale to MTD
Swiss medical technology company Ypsomed has signed an agreement to sell its pen needle and blood glucose monitoring systems (BGMs) businesses to Medical Technology and Devices (MTD). The sale ...
Hosted on MSN29d
“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology Ypsomed could include the supply of injection pens for CagriSema, the former’s ...